biotech / news / / The Financial Express
Wegovy, Ozempic and Rybelsus are sold directly by Novo.
Novo reduced Ozempic's starting dose price by 36% and Wegovy's by 48% after generics launched.
KEY POINTS
- The GLP-1 market in India tripled to Rs 1,736 crore due to generic semaglutide launches.
- Torrent Pharma now controls 38% of India's generic semaglutide market and offers the only oral generics.
- Sales of generic semaglutide jumped 238% in April compared to March, impacting tirzepatide sales.
- Innovator brands have retained strong market positions despite significant growth in generics.
COMPANIES
Summarized by Newsio from The Financial Express. How we summarize →